中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 4
Apr.  2018
Turn off MathJax
Article Contents

Clinical effect of transarterial chemoembolization combined with radiofrequency ablation in treatment of rabbit VX2 liver tumors

DOI: 10.3969/j.issn.1001-5256.2018.04.017
Research funding:

 

  • Published Date: 2018-04-20
  • Objective To investigate the clinical effect of transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) (TACE + RFA) versus RFA or TACE alone in the treatment of rabbit VX2 hepatic tumors and related pathological changes.Methods The rabbits were sacrificed at 7 days after surgery, and the maximal diameter of coagulative necrotic zone or hemorrhagic infarct zone was compared, as well as typical pathological sections.An analysis of variance was used for comparison of continuous data between multiple groups, and the least significant difference t-test was used for further comparison between two groups.Results One rabbit in the RFA group died of pneumothorax and one in the TACE + RFA group died of extensive liver necrosis at 2 days after surgery.The other 16 rabbits survived to the end of observation, resulting in a success rate of 88.9% (16/18) .There were significant differences between the TACE + RFA group and the other two groups in the maximal long and short diameters of coagulative necrotic zone and tumor cell necrosis rate (all P < 0.05) .The pathological analysis revealed greater vascular thrombosis, larger necrotic zone, and fewer clusters of viable tumor cells in the TACE + RFA group, compared with the other groups.Conclusion TACE + RFA has a better effect in tumor destruction than RFA or TACE alone.

     

  • loading
  • [1]HAN K, KIM JH.Transarterial chemoembolization in hepatocellular carcinoma treatment:Barcelona clinic liver cancer staging system[J].World J Gastroenterol, 2015, 21 (36) :10327-10335.
    [2]GAO HJ, CHEN MS.Radiofrequency ablation for the treatment of hepatocellular carcinoma[J].J Clin Hepatol, 2012, 28 (4) :249-252. (in Chinese) 高恒军, 陈敏山.原发性肝癌的射频消融治疗[J].临床肝胆病杂志, 2012, 28 (4) :249-252.
    [3]LI HL, JI WB, ZHAO R, et al.Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation:retrospective analysis[J].World J Gastroenterol, 2015, 21 (12) :3599-3606.
    [4]SPREAFICO C, CASCELLA T, FACCIORUSSO A, et al.Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads:clinical-radiological outcomes and safety profile[J].Cardiovasc Intervent Radiol, 2015, 38 (1) :129-134.
    [5]MURAKAMI T, ISHIMARU H, SAKAMOTO I, et al.Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma:rate and risk factors for local recurrence[J].Cardiovasc Intervent Radiol, 2007, 30 (4) :696-704.
    [6]IKEDA K, OSAKI Y, NAKANISHI H, et al.Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma[J].Oncology, 2014, 87 (Suppl 1) :73-77.
    [7]LYU TS, ZOU YH, WANG J, et al.Current status of transcatheter arterial chemoembolization combined with radiofrequency ablation in treatment of primary liver cancer[J].J Clin Hepatol, 2016, 32 (1) :49-55. (in Chinese) 吕天石, 邹英华, 王健, 等.经肝动脉化疗栓塞术联合射频消融治疗原发性肝癌的现状[J].临床肝胆病杂志, 2016, 32 (1) :49-55.
    [8]SONG J, WANG Y, MA K, et al.Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single, small hepatocellular carcinomas[J].Surg Endosc, 2016, 30 (10) :4249-4257.
    [9]BIMONTE S, LEONGITO M, PICCIRILLO M, et al.Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment[J].Infect Agent Cancer, 2016, 11:38.
    [10]DUAN XH, LI TF, ZHOU GF, et al.Transcatheter arterial embolization combined with radiofrequency ablation activates CD8+T-cell infiltration surrounding residual tumors in the rabbit VX2 liver tumors[J].Onco Targets Ther, 2016, 9:2835-2844.
    [11]ROSSI S, GARBAGNATI F, LENCIONI R, et al.Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply[J].Radiology, 2000, 217 (1) :119-126.
    [12]MOSTAFA EM, GANGULI S, FAINTUCH S, et al.Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors[J].J Vasc Interv Radiol, 2008, 19 (12) :1740-1748.
    [13]IEZZI R, POMPILI M, POSA A, et al.Combined locoregional treatment of patients with hepatocellular carcinoma:state of the art[J].World J Gastroenterol, 2016, 22 (6) :1935-1942.
    [14]WU HP, LIANG HM, ZHENG CS, et al.Lipiodol flowing into portal vein after hepatic artery embolization:the influential factors and its clinical significance[J].J Clin Radiol, 2005, 24 (5) :429-433. (in Chinese) 吴汉平, 梁惠民, 郑传胜, 等.肝动脉栓塞碘油进入门静脉的相关因素及其临床意义[J].临床放射学杂志, 2005, 24 (5) :429-433.
    [15]LENCIONI R, CROCETTI L, PETRUZZI P, et al.Doxorubicineluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma:a pilot clinical study[J].J Hepatol, 2008, 49 (2) :217-222.
    [16]KONG G, ANYARAMBHATLA G, PETROS WP, et al.Efficacy of liposomes and hyperthermia in a human tumor xenograft model:importance of triggered drug release[J].Cancer Res, 2000, 60 (24) :6950-6957.
    [17]HIGUCHI T, KIKUCHI M, OKAZAKI M.Hepatocellular carcinoma after transcatheter hepatic arterial embolization.A histopathologic study of 84 resected cases[J].Cancer, 1994, 73 (9) :2259-2267.
    [18]DUDAR TE, JAIN RK.Differential response of normal and tumor microcirculation to hyperthermia[J].Cancer Res, 1984, 44 (2) :605-612.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2204) PDF downloads(404) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return